• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

ECDC: Avian influenza overview September–November 2025

Commonground

Senior Moderator
APPROVED: 10 December 2025

European Food Safety Authority,

European Centre for Disease Prevention and Control,

European Union Reference Laboratory for Avian Influenza, Hubert

Buczkowski, Mariette Ducatez, Alice Fusaro, Jose L Gonzales, Thijs Kuiken,

Gražina Mirinavičiūtė, Karl Ståhl, Christoph Staubach, Olov Svartström,

Calogero Terregino, Katriina Willgert, Evelyn Alarcón and Lisa Kohnle


Abstract

Between 6 September and 28 November 2025, 2,896 highly pathogenic avian influenza

(HPAI) A(H5) virus detections were reported in domestic (442) and wild (2,454) birds in

29 countries in Europe. The magnitude and geographical extent of these detections were

unprecedented for this time of the year, particularly in wild birds. Large numbers of

waterfowl were affected by the disease, and mass mortality of common cranes was

observed along their migratory routes in Europe. Given the high levels of virus circulation

in wild birds and the resulting high environmental contamination, most HPAI outbreaks in

domestic birds were primary, with indirect contact with wild birds being the most likely

source of infection. Among poultry species, turkeys were proportionally the most affected,

and HPAI outbreaks were once again reported in vaccinated ducks. A slight increase in

HPAI virus detections in mammals was noted among foxes and domestic cats in Europe,

consistent with the increase in detections in wild birds. Between 9 September and 28

November 2025, 19 cases of avian influenza virus infection in humans, including two

deaths, were reported in four countries: Cambodia (three A(H5N1) cases, one death),

China (14 A(H9N2) cases), Mexico (one A(H5N2) case), and United States of America

(USA) (one fatal A(H5N5) case). All of the A(H5) human cases (n = 5/5) reported exposure

to poultry or a poultry environment prior to detection or onset of illness. The current high

level of avian influenza virus in bird populations increases the risk of human exposure to

infected animals. Nevertheless, given the widespread circulation of avian influenza viruses

in animal populations, human infections remain rare. No instances of human-to-human

transmission were documented during the reporting period. The risk posed by avian

A(H5N1) clade 2.3.4.4b influenza viruses currently circulating in Europe remains low for

the general public in the European Union/European Economic Area and low-to-moderate

for those occupationally or otherwise exposed to infected animals or contaminated

environments.

https://www.ecdc.europa.eu/sites/default/files/documents/AI-Report-XXXV.pdf
 
Back
Top